Table 1 Summary of clinical information of all cases harboring 13q12.2 focal amplification
From: Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
Patient ID | Disease stage (TC) | Disease stage (PC) | Location | cM (TC) | cM (PC) | TBC (months) | Detection* |
|---|---|---|---|---|---|---|---|
C74 | IV B | IV B | Rectum | M1 | M1 | 22.8 | Yes |
C79 | NA | NA | NA | NA | NA | NA | No |
C95 | II A | IV B | Left flexure | M0 | M1 | 43.4 | NA |
C109 | III B | IV B | Rectum | M0 | M1 | 101.7 | Yes |
C110 | IV A | IV B | Colon ascending | M1 | M1 | 0.7 | NA |
C118 | IV B | IV B | Colon sigmoid | M0 | M1 | 22.9 | No |
C112 | III A | IV B | Rectum | NA | NA | 27.1 | NA |
C123 | III B | IV B | Colon sigmoid | M0 | M1 | 76.5 | Yes |
C129 | I | IV B | Colon sigmoid | M0 | M1 | 121.3 | NA |
C166 | IV A | IV A | Colon transverse | M1 | M1 | 0.7 | No |
C178 | III C | IV B | Cecum | M0 | M1 | 5.4 | Yes |
C206 | III B | III B | Rectum | M0 | M0 | 7.6 | No |
C240 | III B | IV B | Colon sigmoid | M0 | M1 | 79.9 | No |
C216+ | NA | IV B | NA | NA | NA | NA | NA |